Meta Biomed Co. Ltd (059210) — Capital Reinvestment Ratio
Meta Biomed Co. Ltd (059210) has a Capital Reinvestment Ratio of 4.21x as of September 2025, meaning it reinvests 4% of its operating cash flow (₩1.05 Billion) in capital expenditures (₩4.44 Billion). Check 059210 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Meta Biomed Co. Ltd Capital Reinvestment Ratio (2011–2024)
This chart tracks Meta Biomed Co. Ltd's Capital Reinvestment Ratio across 11 annual periods. For the full cash flow conversion analysis, see Meta Biomed Co. Ltd cash conversion from operations.
Annual Capital Reinvestment Ratio for Meta Biomed Co. Ltd (2011–2024)
Year-by-year Capital Reinvestment Ratio for Meta Biomed Co. Ltd from 2011 to 2024. See free cash flow generation of Meta Biomed Co. Ltd to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.49x | ₩22.63 Billion | ₩11.10 Billion | ▼ -56.4% |
| 2023 | 1.12x | ₩10.22 Billion | ₩11.49 Billion | ▼ -33.1% |
| 2022 | 1.68x | ₩9.16 Billion | ₩15.41 Billion | ▲ +806.2% |
| 2021 | 0.19x | ₩11.14 Billion | ₩2.07 Billion | ▼ -59.5% |
| 2020 | 0.46x | ₩4.86 Billion | ₩2.23 Billion | ▼ -82.6% |
| 2019 | 2.64x | ₩2.86 Billion | ₩7.56 Billion | ▲ +116.8% |
| 2016 | 1.22x | ₩5.03 Billion | ₩6.13 Billion | ▼ -22.9% |
| 2015 | 1.58x | ₩4.93 Billion | ₩7.79 Billion | ▲ +27.5% |
| 2013 | 1.24x | ₩3.71 Billion | ₩4.60 Billion | ▼ -9.7% |
| 2012 | 1.37x | ₩3.83 Billion | ₩5.26 Billion | ▼ -31.5% |
| 2011 | 2.00x | ₩4.10 Billion | ₩8.22 Billion | — |